myeloproliferative syndrome
Showing 1 - 10 of 10
Epidemiological and Clinical-pathological Factors of
Completed
- Myeloproliferative Neoplasm
- +4 more
-
Guayaquil, Guayas, EcuadorSociedad de Lucha Contra el Cáncer
Apr 25, 2023
Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,
Recruiting
- Colorectal Cancer
- +11 more
- Vactosertib
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023
Acute Leukemia in Remission, MDS, Myeloproliferative Syndrome Trial (Fecal Microbiota Transplantation)
Not yet recruiting
- Acute Leukemia in Remission
- +6 more
- Fecal Microbiota Transplantation
-
Amiens, France
- +19 more
Oct 18, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical
Recruiting
- Acute Myeloid Leukemia
- +10 more
- TCRαβ+/CD19+ depleted Haploidentical HSCT
- Zoledronate
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 1, 2022
Acute Myeloid Leukemia, Myeloproliferative Syndrome Trial in France (CPX-351)
Not yet recruiting
- Acute Myeloid Leukemia
- Myeloproliferative Syndrome
-
Amiens, France
- +33 more
Feb 7, 2022
Acute Myeloid Leukemia in Remission, MDS, Chronic Myeloid Leukemia in Remission Trial in Belgium (Thymoglobulin, Melphalan,
Recruiting
- Acute Myeloid Leukemia in Remission
- +9 more
- Thymoglobulin
- +3 more
-
Antwerp, Belgium
- +9 more
Oct 5, 2021
Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory
Recruiting
- Myeloid Leukemia, Chronic
- +8 more
- Conventional T cells (Tcon) and Regulatory T cells (Treg)
-
Palo Alto, CaliforniaStanford University School of Medicine Palo Alto, California, Un
Aug 18, 2021
Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia Trial in Cleveland (radiation, drug, procedure,
Completed
- Acute Myeloid Leukemia
- +10 more
- total marrow irradiation
- +7 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
May 5, 2021
Myeloproliferative Disorder, Myeloproliferative Syndrome, Myelofibrosis Trial in Irvine (USDA Diet, Mediterranean Diet)
Completed
- Myeloproliferative Disorder
- +4 more
- USDA Diet
- Mediterranean Diet
-
Irvine, CaliforniaUniversity of California, Irvine
Mar 23, 2020
Heat-shock Protein Inhibitors in Myeloproliferative Syndromes
Completed
- Myeloproliferative Syndrome
- Blood sample
- +2 more
-
Dijon, FranceCHU Dijon Bourgogne
Aug 16, 2016